🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementGLP-1 and gastroparesis — when delayed emptying becomes pathological

GLP-1 and gastroparesis — when delayed emptying becomes pathological

Dr.GutHealth Fri, Jun 5, 2026 at 12:16 AM 8 replies 324 viewsPage 1 of 2
Dr.GutHealth
Senior Member
1,456
7,890
Mar 2024
Minnesota
Jun 5, 2026 at 12:16 AM#1

Putting this up now rather than when I am certain, because by then it will not help anybody.

Constipation replaced nausea at around week five and has been the more persistent of the two by a wide margin.

One important qualification: fiber without adequate fluid is worse than no fiber. If intake is down, fluid is usually down too, and adding bulk to a dry system is how people end up in real trouble.

What to check: Soluble versus insoluble is the distinction that matters: psyllium and oat beta-glucan hold water; wheat bran adds bulk. On slowed transit with low intake, the first helps and the second often does not.

If your experience contradicts this, say so in the thread — I would rather be corrected here than have people act on a warning that does not hold.

12 7VanRx_Mike, steve_okc, dave_SLC and 9 others
Reply Quote Save Share Report
mike_nyc
VIP Member
5,678
21,345
Nov 2023
New York
Online
Jun 5, 2026 at 1:42 AM#2
Dr.GutHealth said:
Constipation replaced nausea at around week five and has been the more persistent of the two by a wide margin.

That is correct as far as it goes, and here is where it stops going. Fiber trials in this population are thin, and most of what gets quoted is extrapolated from idiopathic constipation in people eating normally. The extrapolation is not unreasonable but it is an extrapolation, and it fails specifically for insoluble fiber at low intake — the case that comes up here most often.

11 6stefan_berlin, Dr.EM_Chicago, pete_RVA and 8 others
Reply Quote Save Share Report
LibrarianMeg
Senior Member
1,678
7,890
Mar 2024
Baltimore, MD
Jun 5, 2026 at 3:07 AM#3
Dr.GutHealth said:
Constipation replaced nausea at around week five and has been the more persistent of the two by a wide margin.

Worth saying plainly that not all of this is benign. Severe constipation on delayed gastric emptying has produced obstruction and ileus cases, rarely but genuinely. Pain with vomiting and no bowel movement is not a fiber conversation.

10 5julia.endo, JessicaM_2024, TomFromTexas and 7 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.CardioMD
VIP Member
2,678
14,567
Dec 2023
Cleveland, OH
Jun 5, 2026 at 4:33 AM#4

Taking the question as asked, rather than the general version of it. The mechanism is slowed transit plus reduced intake, and that combination determines which interventions work. Less food means less bulk, slower motility means more water reabsorbed, and the result is a smaller, drier, slower stool. Insoluble fiber adds bulk to a system that is already moving slowly, which is why it frequently makes things worse. Soluble fiber holds water and is the better first choice, and an osmotic agent works with the mechanism rather than against it.

9 4roxy_nash, tony_orlando, Dr.NephBHM_UK and 6 others
Reply Quote Save Share Report
andrew_nyc
Member
534
2,345
Apr 2024
New York, NY
Jun 5, 2026 at 1:06 PM#5
mike_nyc said:
Fiber trials in this population are thin, and most of what gets quoted is extrapolated from idiopathic constipation in people eating normally.

Second this. Nothing to add that would improve it.

Last edited: Jun 5, 2026 at 6:06 PM
8 3JessicaM_2024, TomFromTexas, mike.trainer_LA and 5 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register